POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 53 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79,125 | -71.2% | 33,246 | -78.7% | 0.00% | – |
| Q2 2023 | $274,498 | -67.6% | 155,965 | -43.2% | 0.00% | – |
| Q1 2023 | $846,088 | +82.6% | 274,704 | +214.3% | 0.00% | – |
| Q4 2022 | $463,289 | -64.9% | 87,413 | -76.6% | 0.00% | – |
| Q3 2022 | $1,320,000 | +605.9% | 374,138 | +415.5% | 0.00% | – |
| Q2 2022 | $187,000 | +47.2% | 72,574 | +156.1% | 0.00% | – |
| Q1 2022 | $127,000 | -25.3% | 28,337 | +13.3% | 0.00% | – |
| Q4 2021 | $170,000 | +107.3% | 25,014 | +121.4% | 0.00% | – |
| Q3 2021 | $82,000 | -60.6% | 11,300 | -45.4% | 0.00% | – |
| Q2 2021 | $208,000 | -85.3% | 20,710 | -86.1% | 0.00% | – |
| Q1 2021 | $1,419,000 | +259.2% | 148,658 | +234.0% | 0.00% | – |
| Q3 2020 | $395,000 | – | 44,515 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 3,567,985 | $8,491,804 | 2.58% |
| Aisling Capital Management LP | 1,043,267 | $2,482,975 | 1.02% |
| Atom Investors LP | 156,168 | $371,680 | 0.08% |
| Pentwater Capital Management LP | 5,975,000 | $14,220,500 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 79,709 | $189,707 | 0.04% |
| Forefront Analytics, LLC | 24,969 | $59,428 | 0.03% |
| Callan Capital, LLC | 76,559 | $182,210 | 0.02% |
| XTX Topco Ltd | 40,782 | $97,061 | 0.02% |
| Advisory Services Network, LLC | 257,271 | $612,305 | 0.02% |
| RBF Capital, LLC | 70,171 | $167,007 | 0.01% |